Building a Biotech Startup with Dr. Tony Vanden Bush CEO of Syntherna

Share with your friends

Listen on Apple Podcast Badge
Listen on Spotify Badge

In this exclusive interview, Dr. Tony Vanden Bush, CEO of Syntherna explains the intricacies of biotech entrepreneurship, the challenges of scaling scientific discoveries, the biotech commercialization process, and the leadership lessons learned along the way.

With a strong background in biochemistry and immunology, Dr. Vanden Bush has traversed a unique path, from academia to becoming a serial biotech entrepreneur, and he shares his journey with candid reflections and valuable advice.

From Academic Ambitions to Biotech Entrepreneurship

Dr. Vanden Bush’s career trajectory was altered by the 2008 economic downturn, which led him away from his initial goal of becoming a faculty member and into the world of biotech startups. He co-invented and patented vaccine technologies, which became the foundation for his first company. Reflecting on his shift from academia to entrepreneurship, he says, “It was traumatic at the time, but it turned out to be a meeting of two worlds that was serendipitous and very good for me.”


Rage-free Iowa news for your inbox

Justin, David, & Kaylee cover Iowa news, agriculture, business and tech. No clickbait. No rage. No agenda. Support our vision and subscribe!


Despite the challenges of launching biotech ventures, including navigating complex regulations and securing niche expertise, Dr. Vanden Bush highlights the satisfaction of merging his scientific knowledge with entrepreneurial drive. He advises aspiring entrepreneurs to remain adaptable, noting, “Don’t be afraid to pivot. Most of the success I’ve had came from adjusting to feedback and shifting our focus.”

Syntherna’s Vision: Revolutionizing Vaccine and Therapeutic Delivery

When discussing the differences between biotech and other industries, Dr. Vanden Bush emphasizes the depth of expertise required in biotech. Unlike more general fields like software development, biotech demands a precise understanding of highly specialized scientific processes. “If I want to build a vaccine on a new platform, only those who developed that platform will understand it,” he explains.

Moreover, the stakes are higher in biotech due to regulatory hurdles and the need for products to demonstrate significant scientific validation before they can be commercialized. As Dr. Vanden Bush puts it, “You have to do the hard experiments early to de-risk your platform. Failure is the only time you really learn anything.”

Dr. Tony Vanden Bush

Syntherna, a company focused on RNA-based therapeutics and next-generation vaccine delivery technologies, aims to make vaccine production faster, cheaper, and more efficient. While the COVID-19 pandemic spotlighted RNA vaccines, Syntherna seeks to improve upon those first-generation platforms. Dr. Vanden Bush reveals that their technology could reduce manufacturing costs by up to 70%, which could be transformative for industries like agriculture, where cost-effective animal vaccines are crucial.

Looking ahead, Dr. Vanden Bush sees partnerships as essential for Syntherna’s growth, especially in a field as resource-intensive as biotech. “We need strategic partnerships to test our platforms and help bring our innovations to market,” he says.

Leadership and Advice for Aspiring Entrepreneurs

Dr. Vanden Bush’s leadership philosophy centers on valuing and empowering his team. He believes in hiring good people and then giving them the autonomy to excel. He also stresses the importance of understanding every aspect of the business, even areas outside one’s expertise, to make informed decisions.

For those starting their entrepreneurial journey, Dr. Vanden Bush offers practical advice: “Listen to the market and don’t build a product just for yourself. If the market doesn’t think it’s worth it, it never will be.”

Key Takeaways for Biotech Entrepreneurs:

  • Adaptability is crucial: Be prepared to pivot based on market feedback.
  • Understand your industry’s complexities: Biotech innovation requires deep technical expertise and careful navigation of regulatory environments.
  • Strategic partnerships are vital: Collaboration with larger companies can help bring new technologies to market more efficiently.
  • Value your team: Successful companies are built by empowered and valued employees.

This episode offers a deep dive into the challenges and opportunities of biotech entrepreneurship, guided by the experiences and wisdom of Dr. Tony Vanden Bush.